Article ; Online: Delayed vascular complication after collagenase injection for Dupuytren disease.
2023 Volume 24, Issue 1, Page(s) 837
Abstract: Background: Vascular adverse events after collagenase injection for Dupuytren disease are absent in large trials and systematic reviews. The aim of this study is to present a case series of delayed vascular complications after collagenase treatment.: ... ...
Abstract | Background: Vascular adverse events after collagenase injection for Dupuytren disease are absent in large trials and systematic reviews. The aim of this study is to present a case series of delayed vascular complications after collagenase treatment. Methods: A prospective evaluation of 1181 consecutively treated patients at one orthopedic department identified three patients reporting symptoms of possible vascular complication. Baseline demographics and description of symptoms were collected, with a physical examination documenting extension deficit and neurovascular status. All patients completed the Cold Intolerance Symptom Severity (CISS) scale (range 4-100, lower is better) and underwent Doppler sonography examination of the digital arteries. Results: All patients were treated in the small finger and two had an isolated proximal interphalangeal joint contracture. All patients had a delayed presentation of a few months, with episodes of white discoloration of the treated finger relieved within 30 min and associated with variable pain, paresthesia, stiffness and weakness. Two of the patients reported cold exposure as an episode trigger and had a pathological CISS score (40 and 36, respectively). Doppler sonography identified a nonpatent ulnar digital artery in one patient. Conclusions: Delayed vascular complication after collagenase treatment is rare, but surgeons and patients should be aware of the risk, especially when treating the small finger. |
---|---|
MeSH term(s) | Humans ; Dupuytren Contracture/diagnostic imaging ; Dupuytren Contracture/drug therapy ; Dupuytren Contracture/surgery ; Microbial Collagenase/adverse effects ; Treatment Outcome ; Collagenases/adverse effects ; Injections |
Chemical Substances | Microbial Collagenase (EC 3.4.24.3) ; Collagenases (EC 3.4.24.-) |
Language | English |
Publishing date | 2023-10-23 |
Publishing country | England |
Document type | Journal Article |
ZDB-ID | 2041355-5 |
ISSN | 1471-2474 ; 1471-2474 |
ISSN (online) | 1471-2474 |
ISSN | 1471-2474 |
DOI | 10.1186/s12891-023-06964-z |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.